USFDA concludes inspection at Zydus Cadila’s API manufacturing facilities in Ankleshwar

27 Jul 2019

US Food and Drug Administration (USFDA) has inspected the Zydus Cadila’s API manufacturing facility located at Ankleshwar in Gujarat. The inspection was conducted from July 22, 2019 to July 26, 2019. This audit covered both Unit I and II. At the end of the inspection, no observation (483) is issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Related Cadila Healthcare Ltd. Links:

Cadila Healthcare Share Price

254.00 -0.20 (-0.08%) Nov 22, 10:09
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 454.20
Lupin 773.95
Dr. Reddys Lab 2874.00
Piramal Enterprises 1764.90
Cadila Healthcare 254.00
View more..
Sensex vs Cadila Healthcare
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463